Toxic VC and the Marginal-Dollar Problem

Venture capital has a great expectation for growth and, with it, comes a great pressure to perform. In the quest to grow as big and fast as the Unicorn-crazed market expects, companies find themselves scaling with consequence. After all, not all growth is healthy growth. This article takes a contradictory look at the tough decisions start-ups must face to stay healthy in the face of VC funding.

Key Takeaways:

  • Growth at what cost? Growth without context can quickly become a vanity metric.
  • VCs desire to “go big or go home” and what that means, even for successful teams.
  • Inefficiences at scale can spell disaster (and even death) for a company.

Read the TechCrunch article